A vision for closing the evidence-practice gap in the management of low-grade prostate cancer
JNCI Cancer Spectr
.
2023 Mar 1;7(2):pkad028.
doi: 10.1093/jncics/pkad028.
Authors
Michael S Leapman
1
2
3
,
Stacy Loeb
4
,
Matthew R Cooperberg
5
,
William J Catalona
6
,
Franklin D Gaylis
7
Affiliations
1
Department of Urology, Yale School of Medicine, New Haven, CT, USA.
2
Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, CT, USA.
3
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
4
Departments of Urology and Population Health, New York University Langone Health; Manhattan Veterans Affairs Medical Center, New York, NY, USA.
5
Department of Urology, University of California San Francisco, San Francisco, CA, USA.
6
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
7
Genesis Healthcare Partners, San Diego, CA, USA.
PMID:
37101361
PMCID:
PMC10133397
DOI:
10.1093/jncics/pkad028
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Male
Neoplasm Grading
Professional Practice Gaps*
Prostate
Prostatic Neoplasms* / therapy